 | This article may be too technical for most readers to understand. (March 2021) |
Substituted arylalkylamines are a group of chemical compounds. Two major classes of arylalkylamines include indolylalkylamines (e.g., tryptamines [a.k.a. indolylethylamines]) and phenylalkylamines (e.g., phenethylamines and amphetamines [a.k.a. phenylisopropylamines]), which consist of the monoamine neurotransmitters as well as clinically-used and recreationally-abused monoaminergic drugs, including psychostimulants, anorectics, wakefulness-promoting agents, bronchodilators, decongestants, antidepressants, entactogens, and psychedelics, among others. [1] [2] [3]
See also
References
- ^ Glennon RA (October 1999). "Arylalkylamine drugs of abuse: an overview of drug discrimination studies". Pharmacol. Biochem. Behav. 64 (2): 251–6. doi: 10.1016/S0091-3057(99)00045-3. PMID 10515299. S2CID 10221368.
- ^ Richard K. Ries; Shannon C. Miller; David A. Fiellin (2009). Principles of Addiction Medicine. Lippincott Williams & Wilkins. pp. 245–. ISBN 978-0-7817-7477-2.
- ^ Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 639–. ISBN 978-1-60913-345-0.
 | This article about an amine is a stub. You can help Wikipedia by expanding it. |
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
| This article may be too technical for most readers to understand. (March 2021) |
Substituted arylalkylamines are a group of chemical compounds. Two major classes of arylalkylamines include indolylalkylamines (e.g., tryptamines [a.k.a. indolylethylamines]) and phenylalkylamines (e.g., phenethylamines and amphetamines [a.k.a. phenylisopropylamines]), which consist of the monoamine neurotransmitters as well as clinically-used and recreationally-abused monoaminergic drugs, including psychostimulants, anorectics, wakefulness-promoting agents, bronchodilators, decongestants, antidepressants, entactogens, and psychedelics, among others. [1] [2] [3]
See also
References
- ^ Glennon RA (October 1999). "Arylalkylamine drugs of abuse: an overview of drug discrimination studies". Pharmacol. Biochem. Behav. 64 (2): 251–6. doi: 10.1016/S0091-3057(99)00045-3. PMID 10515299. S2CID 10221368.
- ^ Richard K. Ries; Shannon C. Miller; David A. Fiellin (2009). Principles of Addiction Medicine. Lippincott Williams & Wilkins. pp. 245–. ISBN 978-0-7817-7477-2.
- ^ Thomas L. Lemke; David A. Williams (24 January 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 639–. ISBN 978-1-60913-345-0.
|
| This article about an amine is a stub. You can help Wikipedia by expanding it. |
|
| This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |